SESTINI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 3.750
EU - Europa 2.665
AS - Asia 525
AF - Africa 16
OC - Oceania 2
Totale 6.958
Nazione #
US - Stati Uniti d'America 3.746
RU - Federazione Russa 797
PL - Polonia 772
IT - Italia 276
SE - Svezia 241
IE - Irlanda 238
HK - Hong Kong 153
SG - Singapore 146
CN - Cina 118
UA - Ucraina 113
DE - Germania 97
FI - Finlandia 53
IN - India 39
JO - Giordania 33
GB - Regno Unito 27
CH - Svizzera 17
FR - Francia 16
TR - Turchia 16
CI - Costa d'Avorio 12
VN - Vietnam 10
KR - Corea 7
BE - Belgio 5
NL - Olanda 5
CA - Canada 4
SC - Seychelles 3
AT - Austria 2
CZ - Repubblica Ceca 2
ES - Italia 2
TW - Taiwan 2
AU - Australia 1
IR - Iran 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 6.958
Città #
Warsaw 772
Santa Clara 631
Fairfield 481
Chandler 300
Dublin 238
Woodbridge 236
Ashburn 228
Seattle 204
Cambridge 185
Jacksonville 175
Houston 162
Wilmington 161
Singapore 126
Hong Kong 104
Ann Arbor 92
Princeton 64
Florence 62
Lawrence 59
Altamura 58
Boardman 46
Medford 40
Beijing 38
Buffalo 37
Boston 31
Mumbai 31
Shanghai 30
Moscow 21
Dearborn 20
San Diego 20
Bern 17
Milan 15
Izmir 14
Kent 14
Abidjan 12
New York 12
Norwalk 12
Dong Ket 10
Los Angeles 8
West Jordan 8
Auburn Hills 7
Bremen 7
Yubileyny 7
Frankfurt Am Main 6
Rome 6
Brussels 5
Falls Church 5
Hefei 5
Hillsboro 5
Phoenix 5
Pune 5
Seoul 5
Andover 4
Chicago 4
Chions 4
Kunming 4
Toronto 4
Laurel 3
Padova 3
Redwood City 3
Venezia 3
Anguillara Sabazia 2
Barcelona 2
Bari 2
Bologna 2
Brno 2
Capannori 2
Castellammare Di Stabia 2
Castrolibero 2
Chengdu 2
Dordrecht 2
Greve 2
Guangzhou 2
Latina 2
Lecce 2
London 2
Manduria 2
Munich 2
Nanjing 2
Nanuet 2
Naples 2
Saint Petersburg 2
Secaucus 2
Torino 2
Venice 2
Verona 2
Vienna 2
Washington 2
Acton 1
Almè 1
Arezzo 1
Auckland 1
Bagno A Ripoli 1
Brooklyn 1
Böblingen 1
Castelfranco Di Sopra 1
Castelliri 1
Chieti 1
Chisinau 1
Como 1
Correggio 1
Totale 4.941
Nome #
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis 277
A Founder Effect for the HGD G360R Mutation in Italy: Implications for a Regional Screening of Alkaptonuria 269
High resolution melting analysis for a rapididentification of heterozygous and homozygous sequence changes in the MUTYH gene 259
Endothelin-1: a new autocrine/paracrine factor in rat testis. 256
A systematic assessment of accuracy in detecting somatic mosaic variants by deep amplicon sequencing: Application to NF2 gene 248
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 233
Broadening the spectrum of SMARCB1-associated malignant tumors: A case of uterine leiomyosarcoma in a patient with schwannomatosis 156
PREMATURE OVARIAN FAILURE AND FRAGILE X PREMUTATION: A STUDY ON 45 WOMEN 140
Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. 136
Genetic insights into familial tumors of the nervous system. 132
Expanding the mutational spectrum of LZTR1 in schwannomatosis. 132
Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection 128
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. 127
Application of COLD-PCR for improved detection of NF2 mosaic mutations 127
Multiple spinal ganglioneuromas in a patient harboring a pathogenic NF1 mutation. 126
A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. 124
A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency 124
The use of COLD-PCR and High Resolution Melting Analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer 122
Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation 121
Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell line. 119
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 118
The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy. 118
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. 115
Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma 115
Sonde di DNA con rivelazione in chemiluminescenza 113
An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene. 113
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 112
Detection of rearrangements in the NF2 gene using semi-quantitative multiplex fluorescent PCR. 109
Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique 108
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis. 106
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 105
Triple synchronous cutaneous melanoma: a clinical, dermoscopic, and genetic case study. 103
Epigenomic, genomic, and transcriptomic landscape of schwannomatosis 99
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 98
Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. 97
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. 97
Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors 97
Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene. 96
The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples. 93
Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors. 93
MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria. 90
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations. 89
Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 oncogene amplification in DNA from human tumours. 89
Malignant extra-adrenal pheochromocytoma caused by an SDHB intronic variation leading to a 54-bp deletion in exon 4. 88
QUANTITATIVE POLYMERASE CHAIN REACTION-BASED HOMOGENEOUS ASSAY WITH FLUOROGENIC PROBES TO MEASURE C-ERBb-2 ONCOGENE AMPLIFICATION. 87
Detection of BRCA1 and BRCA2 variants in circulating free DNA by using a commercial kit 87
Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. 85
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction 84
Expression of GLI-1 and cytoplasmic and secretory proteins in a human basal keratinocyte cell line. 84
Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population 83
A new and simple method for HLA-B*5701 screening before abacavir treatment 81
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 79
Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes 77
Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction. 76
Schwannomatosis associated schwannomas show a different NF2 mutational spectrum compared to Neurofibromatosis type 2 patients 75
The use of COLD-PCR and high-resolution melting analysis improbe the limito f detection of KRAS and BRAF mutations in colorectal cancer 71
Consequences of modulating GLI-1 expression in a basal carcinoma cell line. 66
Tacrolimus reduces the expression of GLI-1 by basal cell carcinoma. 58
Effects of reduced expression of GLI-1 gene in a basal carcinoma cell line. 58
Partial inhibition of GLI-1 transcription in basal cell carcinoma cells induced by tacrolimus (FK506): an in vitro study. 52
Totale 7.020
Categoria #
all - tutte 18.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020938 0 0 0 0 140 163 147 170 127 71 104 16
2020/2021716 73 53 71 87 25 74 20 73 49 108 32 51
2021/2022436 19 38 43 14 11 17 14 35 19 14 92 120
2022/20231.184 102 217 48 93 90 209 153 74 131 13 31 23
2023/2024425 12 48 57 29 26 42 14 124 12 17 27 17
2024/20251.804 72 283 195 497 757 0 0 0 0 0 0 0
Totale 7.020